These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20621223)

  • 21. Reversal of neuromuscular block: the case FOR reversal.
    Bevan D
    Acta Anaesthesiol Scand Suppl; 1997; 110():102. PubMed ID: 9248550
    [No Abstract]   [Full Text] [Related]  

  • 22. Recovery from neuromuscular block and vital function testing.
    Eriksson LI
    Acta Anaesthesiol Belg; 1997; 48(1):45-8. PubMed ID: 9099308
    [No Abstract]   [Full Text] [Related]  

  • 23. Adequate confirmation of recovery from neuromuscular blockade: what are the obstacles?
    Caruso L; Urdaneta F
    Can J Anaesth; 2014 Jan; 61(1):82. PubMed ID: 24203502
    [No Abstract]   [Full Text] [Related]  

  • 24. Residual neuromuscular blockade: a persistent clinical problem.
    Pino RM
    Int Anesthesiol Clin; 2006; 44(2):77-90. PubMed ID: 16849957
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuromuscular monitoring, residual blockade, and reversal: time for re-evaluation of our clinical practice.
    Plaud B
    Can J Anaesth; 2013 Jul; 60(7):634-40. PubMed ID: 23661296
    [No Abstract]   [Full Text] [Related]  

  • 26. Apnea after reversal of neuromuscular blockade. A case of rare mix-up.
    Ansari MM; Magaji GK; Abraham A
    Saudi Med J; 2007 Apr; 28(4):641-2. PubMed ID: 17457497
    [No Abstract]   [Full Text] [Related]  

  • 27. [Reversion of sedation and general anaesthesia--agonist-antagonist technique].
    Matveeva OB; Mizikov VM
    Anesteziol Reanimatol; 2014; 59(5):37-41. PubMed ID: 25842939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative residual curarisation: complication or malpractice?
    Cammu G
    Acta Anaesthesiol Belg; 2004; 55(3):245-9. PubMed ID: 15515302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendations on the use of deep neuromuscular blockade by anaesthesiologists and surgeons. AQUILES (Anestesia QUIrúrgica para Lograr Eficiencia y Seguridad) Consensus.
    Errando-Oyonarte CL; Moreno-Sanz C; Vila-Caral P; Ruiz de Adana-Belbel JC; Vázquez-Alonso E; Ramírez-Rodríguez JM; Veiga-Ruiz G; Guasch-Arévalo E; Lora-Tamayo D'Ocón JI
    Rev Esp Anestesiol Reanim; 2017 Feb; 64(2):95-104. PubMed ID: 27692692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Not just monitoring; a strategy for managing neuromuscular blockade.
    Rodney G; Raju PK; Ball DR
    Anaesthesia; 2015 Oct; 70(10):1105-9. PubMed ID: 26372860
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuromuscular blocking drugs and their antagonists in patients with organ disease.
    Craig RG; Hunter JM
    Anaesthesia; 2009 Mar; 64 Suppl 1():55-65. PubMed ID: 19222432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An algorithm for train-of-four monitoring in patients receiving continuous neuromuscular blocking agents.
    Jones SK
    Dimens Crit Care Nurs; 2003; 22(2):50-7; quiz 58-9. PubMed ID: 12649615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromuscular blockade and minimal monitoring.
    Sweeney BP
    Anaesthesia; 2010 Mar; 65(3):308. PubMed ID: 20236270
    [No Abstract]   [Full Text] [Related]  

  • 34. Consensus Statement on Perioperative Use of Neuromuscular Monitoring.
    Naguib M; Brull SJ; Kopman AF; Hunter JM; Fülesdi B; Arkes HR; Elstein A; Todd MM; Johnson KB
    Anesth Analg; 2018 Jul; 127(1):71-80. PubMed ID: 29200077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery from neuromuscular blockade and routine monitoring of neuromuscular function.
    Viby-Mogensen J; Claudius C
    Anaesthesia; 2007 Dec; 62(12):1292-4; author reply 1294. PubMed ID: 17991272
    [No Abstract]   [Full Text] [Related]  

  • 36. Residual Neuromuscular Blockade.
    Plummer-Roberts AL; Trost C; Collins S; Hewer I
    AANA J; 2016 Feb; 84(1):57-65. PubMed ID: 26939390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual neuromuscular blockade: importance of upper airway integrity.
    Gal TJ
    Anesthesiology; 2004 Feb; 100(2):457; author reply 458. PubMed ID: 14739831
    [No Abstract]   [Full Text] [Related]  

  • 38. A survey of the management of neuromuscular blockade monitoring in Australia and New Zealand.
    Phillips S; Stewart PA; Bilgin AB
    Anaesth Intensive Care; 2013 May; 41(3):374-9. PubMed ID: 23659401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why, how and when to monitor neuromuscular function.
    Viby-Mogensen J
    Minerva Anestesiol; 1999 May; 65(5):239-44. PubMed ID: 10389398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.
    Kleinpell R; Bedrosian C; McCormick L; Kremer M; Bujalski L; Bronsted R
    Am J Crit Care; 1996 Nov; 5(6):449-54. PubMed ID: 8922161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.